光学相干断层显像观察强化他汀治疗对支架内新生内膜的影响

孟培娜; 钟赟; 尤威; 吴志明; 陈芡如; 陈绍良; 叶飞

doi:10.13201/j.issn.1001-1439.2016.10.007

光学相干断层显像观察强化他汀治疗对支架内新生内膜的影响

- 南京医科大学附属南京医院南京市第一医院心血管内科(南京, 210006)

详细信息

通讯作者: 叶飞,E-mail:yefei@medmail.com.cn

中图分类号: R542.2

收稿日期: 2016-03-23

修回日期: 2016-06-21

Effect of intensive statins to in-stent neointima from optical coherence tomography observations

- Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, China

More Information

Corresponding author: YE Fei, E-mail: yefei@medmail.com.cn

Received Date: 23 March 2016

Revised Date: 21 June 2016

摘要

摘要: 目的:通过光学相干断层显像(OCT)分析强化他汀治疗对支架内膜增生的的影响。方法:入选2014-01-2016-02在我院心内科行冠脉造影+经皮冠状动脉支架植入术(PCI)治疗并予术后1年后行OCT复查的患者44例分为2组:强化剂量他汀治疗组(强化组,阿托伐他汀40mg/d或瑞舒伐他汀20mg/d),常规剂量他汀治疗组(常规组,阿托伐他汀20mg/d、10mg/d或瑞舒伐他汀10mg/d、5mg/d);比较2组之间的临床基线水平、PCI术中参数及复查OCT指标的差异;结果:2组患者的临床基线资料、PCI术中各项参数指标类似,OCT结果发现强化组支架内膜增生厚度较常规组更薄[(212.86±85.16)μm∶(355.65±155.62)μm,P<0.05],同质性比例更高(81.0%∶47.8%,P<0.05)。结论:强化他汀治疗能够抑制支架内膜增生,且发生同质性比例相对更高,可能对稳定内膜及降低支架内再狭窄更具有优势。
- 光学相干断层显像 /
- 他汀 /
- 支架内膜增生 /
- 同质性 /
- 异质性
Abstract: Objective:Neointimal hyperplasia is the leading cause of in-stent restenosis.OCT is a superior intravascular imaging modality with a higher resolution to discriminate morphological features of neointima(homogeneous and heterogeneous optical properties).The aim of this study is to assess the effect of intensive statins to instent neointimal hyperplasia from OCT obversations.Method:The study population consisted of 44 patients with 44drug-eluting stent-treated lesions.Patients received a follow-up OCT examination without any other intervention after about 12 months of statins using.They were divided into two groups:first group:intensive dose group(21patients,atorvastatin 40mg/d or rosuvastatin 20mg/d)and second group:conventional dose group(23patients,atorvastatin 20mg/d,10 mg/d or rosuvastatin 10 mg/d,5 mg/d),then compared the difference of the two groups.Result:There were no differences of clinical characteristics and parameters during PCI procedural between the two groups.OCT imagings indicated that in-stent neointima was thinner[(212.86±85.16)μm vs(355.65±155.62)μm,P<0.05]and homogeneity occupied higher proportion in the first group compared with second group(81.0% vs 47.8%,P<0.05).Conclusion:Intensive dose statins could depress in-stent neointimal hyperplasia and may induce higher proportion of homogeneous property,it may stabilize neointima and reduce the incidence of instent restenosis.
- optical coherence tomography /
- statins /
- in-stent neointima /
- homogeneous /
- heterogeneous

HTML全文

参考文献(20)

[1]	MALLE C,TADA T,STEIGERWALD K,et al.Tissue characterization after drug-eluting stent implantation using optical coherence tomography[J].Arterioscler Thromb Vasc Biol,2013,33:1376-1383.
[2]	KIM J S,AFARI M E,HA J,et al.Neointimal patterns obtained by optical coherence tomography correlate with specific histological components and neointimal proliferation in a swine model of restenosis[J].Eur Heart J Cardiovasc Imaging,2014,15:292-298.
[3]	OTAKEA H,SHITEA J,IKENOB F,et al.Evaluation of the peri-strut low intensity area following sirolimus-and paclitaxel-eluting stents implantation:Insights from an optical coherence tomography study in humans[J].Int J Cardiol,2012,157:38-42.
[4]	NAGAI H,ISHIBASHI-UEDA H,FUJII K.Histology of highly echolucent regions in optical coherence tomography images from two patients with sirolimuseluting stent restenosis[J].Catheter Cardiovasc Interv,2010,75:961-963.
[5]	NISSSEN S E,TUZCU E M,SCHOENHAGE P,et al.REVERSAL Investigators.Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis:a randomized controlled trial[J].JAMA,2004,291:1071-1080.
[6]	NISSEN S E,NICHOLLS S J,SIPAHI I,et al.ASTEROID Investigators.Effect of very high-intensity statin therapy on regression of coronary atherosclerosis:the ASTEROID trial[J].JAMA,2006,295:1556-1565.
[7]	RABER L,TANIWAKI M,ZAUGG S,et al.Effect of high-intensity statin therapy on atherosclerosis in noninfarct-related coronary arteries(IBIS-4):a serial intravascular ultrasonography study[J].Eur Heart J,2015,36:490-500.
[8]	NICHOLLS S J,BALLANTYNE C M,BARTER P J,et al.Effects of two intensive statin regimens on progression of coronary disease[J].N Engl J Med,2011,365:2078-2087.
[9]	SCHWARTZ R S,HENRY T D.Pathophysiology of coronary artery restenosis[J].Rev Cardiovasc Med,2002,3:S4-S9.
[10]	GREWE P H,DENEKE T,MACHRAOUI A,et al.Acute and chronic tissue response to coronary stent implantation:Pathologic findings in human specimen[J].J Am Coll Cardiol,2000,35:157-163.
[11]	XU Y,ZHOU S,FANG Z,et al.Inhibition of neointima hyperplasia in rats treated with atorvastatin after carotid artery injury may be mainly associated with down-regulation of survin Fas expression[J],Pharm boil,2014,52:1196-1203.
[12]	JANG J Y,KIM J S,SHIN D H,et al.Favorable effect of optimal lipid-lowering therapy on neointima tissue characteristics after drug-eluting stent implantation:Qualitative optical coherence tomographic analysis[J].Atherosclerosis,2015,242:553-559.
[13]	PRASAD K.Do statins have a role in reduction/prevention of post-PCI restenosis?[J].Cardiovasc Ther,2013,31:12-26.
[14]	FERRO D,PARROTTO S,BASILI S,et al.Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemia[J].J Am Coll Cardiol,2000,36:427-431.
[15]	SUKHOVA G K,WILLIAMS J K,LIBBY P.Statins reduce inflammation in atheroma of nonhuman primates independent of effects on serum cholesterol[J].Arterioscler Thromb Vasc Biol,2002,22:1452-1458.
[16]	MASSARO M,ZAMPOLLI A,SCODITTI E,et al.Statins inhibit cyclooxygenase-2and matrix metalloproteinase-9in human endothelial cells:Anti-angiogenic actions possibly contributing to plaque stability[J].Cardiovasc Res,2010,86:311-320.
[17]	KENT S M,FLAHERTY P J,COYLE L C,et al.Effect of atorvastatin and pravastatin on serum C-reactive protein[J].Am Heart J,2003,145:e8.
[18]	TOUSOULIS D,ANTONIADES C,KOUMALLOS N,et al.Novel therapies targeting vascular Endothelium[J].Endothelium,2006,13:411-421.
[19]	TAM H L,SHIU S W,WONG Y,et al.Effects of atorvastatin on serum soluble receptors for advanced glycation end-products in type 2diabetes[J].Atherosclerosis,2010,209:173-177.
[20]	KOMUKAI K,KUBO T,KITABATA H,et al.Effect of atorvastatin therapy on fibrous cap thickness in coronary atherosclerotic plague as assessed by optical coherence tomography[J].JACC,2014,64:2207-2217.